BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy
暂无分享,去创建一个
I. Bièche | B. Asselain | M. Marty | F. Spyratos | P. de Cremoux | J. Lehmann-Che | V. Scott | A. Hamy | P. Bertheau | J. Guinebretière | A. Hamy | O. Tembo | P. Crémoux | M. Matthieu | B. Sigal‐Zafrani